At this time, posts about Ilyang Pharmaceutical are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 1,000 shares today. Ilyang Pharmaceutical is known as a pharmaceutical company specializing in drinks such as Wonbidi.

As of 11:30 AM on the 4th, Ilyang Pharmaceutical's stock price is 50,600 KRW, up 1.2% from the previous day, with a trading volume of 612,403 shares, which is 12.49% of the 5-day average trading volume. On May 29, Ilyang Pharmaceutical became a market issue with the news of 'COVID-19 treatment clinical trial approval causing consecutive surges.'

In addition to Ilyang Pharmaceutical, posts by investors are also rapidly increasing for Dreamtech (192650), SK (034730), and Hyundai Steel (004020).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing